General Information
Revision date
2019-05-21
Product name
Terbuthylazine-2-hydroxy
CAS No.
66753-07-9
1.2.1 Relevant identified uses
Reference material for laboratory use only
1.2.2. Uses advised against
No further relevant information available
Emergency telephone
department
Icons in SDS
Company Information
company name
LGC Limited
e-mail address of the competent person responsible for the Safety Data Sheet
gb@lgcstandards.com, sds-request@lgcgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H336
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
CLP CLASSIFICATION
GHS07 Skin Irrit. 2 H315 Causes skin irritation. Eye Irrit. 2 H319 Causes serious eye irritation. STOT SE 3 H336 May cause drowsiness or dizziness.
2.2 Label elements
Labelling according to Regulation (EC) No 1272/2008 The substance is classified and labelled according to the CLP regulation.
Hazard pictograms
GHS07
Hazard statements
H315 Causes skin irritation. H319 Causes serious eye irritation. H336 May cause drowsiness or dizziness.
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves / eye protection / face protection. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P321 Specific treatment (see on this label). P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
PBT Substances
Not applicable
vPvB Substances
Not applicable
